| J2182 | Injection, mepolizumab, 1 mg | 23,500 | $20 | $540.5K |
| J2356 | Injection, tezepelumab-ekko, 1 mg | 24,360 | $10 | $341K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,160 | $110 | $122K |
| J1306 | Injection, inclisiran, 1 mg | 10,510 | $10 | $94.6K |
| J0897 | Injection, denosumab, 1 mg | 3,300 | $20 | $59.4K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 230 | $150 | $33.5K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 210 | $140 | $29K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 260 | $70 | $17.3K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 70 | $140 | $9.7K |
| 99496 | The provider manages the care of a patient during the transition to home care after discharge from a healthcare facility. The patient’s care requires high–level medical decision making, contact… | 40 | $240 | $9.2K |